Can autoantibody tests enhance lung cancer screening?—an evaluation of EarlyCDT(®)-Lung in context of the German Lung Cancer Screening Intervention Trial (LUSI)

BACKGROUND: Tumor-associated autoantibodies are considered promising markers for early lung cancer detection; so far, however, their capacity to detect cancer has been tested mostly in a clinical context, but not in population screening settings. This study evaluates the early detection accuracy, in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Lung Cancer Res
Hoofdauteurs: González Maldonado, Sandra, Johnson, Theron, Motsch, Erna, Delorme, Stefan, Kaaks, Rudolf
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AME Publishing Company 2021
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867751/
https://ncbi.nlm.nih.gov/pubmed/33569307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-727
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items